Si-Liang Wang

Prof. Si-Liang Wang

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2024 in International Immunopharmacology
Verified
Journal Article
Closed access
MCMiaomiao Chen
Miaomiao Chen
SWSi-Liang Wang
Si-Liang Wang

22 September 2020 in Disease Markers
Verified
Journal Article
Open access
YSYang Song
Yang Song
MTMei-Yue Tang
Mei-Yue Tang
WCWei Chen
Wei Chen
ZWZhe Wang
Zhe Wang
SWSi-Liang Wang
Si-Liang Wang
Background. Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal malignancies worldwide. The JAK/STAT signaling pathway is involved in pancreatic cancer tumorigenesis. However, the prognostic value of JAK2 expression in resectable PDAC is unclear. Method. In this study, we performed a clinicopathological analysis of 62 resectable PDAC cases with a primary focus on survival. JAK2 expression was examined by immunohistochemistry. The relationship between JAK2 expression and clinicopathological features and prognosis was analyzed. Results. Survival curve analyses revealed that high levels of JAK2 expression predict a poor prognosis in resectable PDAC patients. Multivariate analysis confirmed that JAK2 expression can predict the prognosis of PDAC. Conclusions. Assessment of JAK2 protein expression may be a promising method to predict prognosis in patients with resectable PDAC.

13 June 2019 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
HDH. M. Du
H. M. Du
YWY. J. Wang
Y. J. Wang
XLX. Liu
X. Liu
SWSi-Liang Wang
Si-Liang Wang
SWS. M. Wu
S. M. Wu
XZX. K. Zhu
X. K. Zhu
D-Galactose (D-Gal) promotes accumulation of reactive oxygen species and formation of advanced glycation end-products, ultimately resulting in oxidative stress. D-Gal has been widely used to induce...

19 March 2025 in BioDrugs
Verified
Journal Article
Closed access
PDF file
MCMiaomiao Chen
Miaomiao Chen
YZYuli Zhou
Yuli Zhou
KBKaicheng Bao
Kaicheng Bao
SCSiyu Chen
Siyu Chen
GSGuoqing Song
Guoqing Song
SWSi-Liang Wang
Si-Liang Wang

25 October 2025 in Cellular Signalling
Verified
Journal Article
Closed access
SCSiyu Chen
Siyu Chen
YZYikang Zhao
Yikang Zhao
DCDaopeng Chen
Daopeng Chen
MCMiaomiao Chen
Miaomiao Chen
SWSi-Liang Wang
Si-Liang Wang
YZYi Zhao
Yi Zhao

21 September 2022 in Research Square
Verified
Preprint
Open access
PDF file
MCMiaomiao Chen
Miaomiao Chen
YLYan Lin
Yan Lin
YSYang Song
Yang Song
HDHongmei Du
Hongmei Du
MTMeiyue Tang
Meiyue Tang
SWSi-Liang Wang
Si-Liang Wang
Pancreatic cancer is a gastrointestinal cancer with high mortality. Radiotherapy is an important pancreatic cancer therapy; however, cancer cell resistance to radiotherapy is the major reason for treatment failure. The JAK2/STAT3 (Janus kinase signal transducers 2 and activator of transcription 3) signaling pathway is closely related to the incidence and development of pancreatic cancer, and may be associated with pancreatic cancer resistance to radiotherapy. This study investigated the differences in JAK2 expression in pancreatic cancer irradiated with different doses, also researched the differences in the expression of molecules in the JAK2/STAT3 signaling pathway between pancreatic cancer parental cells and radiotherapy-resistant cells, determined the impact of X-ray irradiation on this signaling pathway, and evaluated enhanced sensitivity to radiotherapy by the JAK2/STAT3 inhibitor, AG490, in pancreatic cancer cells. We show that JAK2 protein expression increased followed an increase in irradiation dose. Compared with parental cells, JAK2 and pSTAT3 were up-regulated in radiotherapy-resistant cells, whereas SOCS3 was down-regulated, X-ray irradiation can activate the JAK2/STAT3 signaling pathway; the combination of siJAK2 transfection with radiotherapy markedly increased cancer cell apoptosis, improving radiotherapy sensitivity of resistant pancreatic cancer cells;AG490, a JAK2-specific inhibitor, decreased radioresistance of pancreatic cancer cells by inhibiting the JAK2/STAT3 signaling pathway. In summary, inhibition of JAK2/STAT3 signaling pathway increases the sensitivity of radiotherapy-resistant pancreatic cancer cells in vitro.